GSK appoints Wunderman SSA to manage key brands

Wunderman Sub-Saharan Africa (SSA) has been appointed to manage four key GlaxoSmithKline (GSK) brands — Grandpa headache powder, Calpol paediatric syrup, Voltaren anti-inflammatory and Otrivin nasal decongestant.

Wunderman Sub-Saharan Africa (SSA ) which is owned by WPP won the pitch after a five-way, multinational agency pitch earlier this year.

Commenting on the new development, Karel Viviers, GSK Africa Media Manager, said the brand had confience in the ability of Wunderman to help it connect with its key markets. “We have full confidence in Wunderman to connect with our target audiences in a way that is effective and relevant,” . They have demonstrated that, even though they are part of a global agency network, they clearly understand, and are in touch with the local market; a critical criterion for the likes of Grandpa.”

In the same vein, Haydn Townsend, Wunderman SSA GCEO said the win represented a remarkable moment fr the agency, adding that the agency relishes the opportunity to help build GSK’s brands.“This is the first big win for the year for our agency, and we’re thrilled to have the opportunity to work through-the-line with this prominent international company on these recognised local and global brands,”

“The timing of this significant win is propitious in the context of the news about Wunderman and J. Walter Thompson’s partnership [in late 2018, WPP announced that Wunderman and J. Walter Thompson would unite to form Wunderman Thompson]. It’s a superb start to 2019 and a prized client to bring into the new, joint agency.”

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world’s sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi

LEAVE A COMMENT

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment

    No comments found.